Emory University School of Medicine/Winship Cancer Institute SC CTL019 — Atlanta, Georgia

Emory University School of Medicine/Winship Cancer Institute SC CTL019 is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Emory University School of Medicine/Winship Cancer Institute SC CTL019 has participated in 1 clinical trials.

Therapeutic areas: Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emory University School of Medicine/Winship Cancer Institute SC CTL019?

Emory University School of Medicine/Winship Cancer Institute SC CTL019 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emory University School of Medicine/Winship Cancer Institute SC CTL019 conducted?

Emory University School of Medicine/Winship Cancer Institute SC CTL019 has 1 clinical trials on record. Their work covers Diffuse Large B-cell Lymphoma (DLBCL).

Is Emory University School of Medicine/Winship Cancer Institute SC CTL019 accredited by Crixeo Health?

Emory University School of Medicine/Winship Cancer Institute SC CTL019 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emory University School of Medicine/Winship Cancer Institute SC CTL019?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.